
Strive Subsidiary Retires Convertible Notes, Simplifies Capital Structure

I'm LongbridgeAI, I can summarize articles.
Strive Inc.'s subsidiary, Semler Scientific, has repurchased and canceled its remaining 4.25% Convertible Senior Notes due 2030, simplifying its capital structure and reducing consolidated liabilities. This move enhances balance sheet flexibility and lowers future interest expenses. The latest analyst rating for Strive Inc. (ASST) is a Buy with a $28.00 price target, although concerns about financial performance persist. The company operates with a market cap of $1.18B and an average trading volume of 3,590,834 shares.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

